- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORNERSTONE THERAPEUTICS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 98,56 | +0,04 % | Aktienmarkt: Kurs der Aktie von Gilead Sciences im Plus (98,5365 €) | Das Wertpapier von Gilead Sciences notiert heute fester. Zuletzt zahlten Investoren für das Papier 115,47 US-Dollar. Die Aktie von Gilead Sciences verzeichnet gegenwärtig einen Wertanstieg von 2,39... ► Artikel lesen | |
| ZOETIS | 127,90 | +0,16 % | Analyst Expectations For Zoetis' Future | ||
| INCYTE | 72,56 | -1,57 % | Incyte stellt neue Daten vor, die Fortschritte im Dermatologie-Portfolio auf dem European Association of Dermatology and Venereology 2025 Congress hervorheben | 24-Wochen-Daten aus dem Phase-3-Studienprogramm STOP-HS zu Povorcitinib bei Patienten mit Hidradenitis suppurativa (HS) wurden als Late-Breaking-Oral-Präsentation ausgewählt
Heute gab Incyte (Nasdaq:... ► Artikel lesen | |
| AMARIN | 12,800 | -0,78 % | Amarin Corporation plc: Amarin Reports Second Quarter 2025 Financial Results | -- European Partnership with Recordati Established to Maximize VAZKEPA® in Europe; Global Corporate Restructuring Implemented with Anticipated $70 Million in Operating Expense Savings Over Next 12... ► Artikel lesen | |
| CASSAVA SCIENCES | 1,846 | +2,56 % | CASSAVA SCIENCES INC - 8-K, Current Report | ||
| ACHIEVE LIFE SCIENCES | 2,690 | -3,93 % | Achieve Life Sciences Announces FDA Acceptance of Cytisinicline NDA (POSITIVE) | ||
| LIGAND PHARMACEUTICALS | 141,00 | -0,70 % | Ligand Pharmaceuticals: Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance | Second quarter performance driven by strong portfolio royalty revenue growth of 57% 2025 full year revenue guidance increased to $200 million - $225 million (previously $180 million - $200 million)... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 371,60 | +1,12 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 0,123 | -8,88 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| TALPHERA | 0,705 | -1,67 % | CorMedix, Inc.: CorMedix Announces Strategic Minority Investment in Talphera | BERKELEY HEIGHTS, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. ("CorMedix") (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for... ► Artikel lesen | |
| ENZON PHARMACEUTICALS | 0,060 | 0,00 % | Enzon Pharmaceuticals, Inc: Enzon and Viskase Enter into Merger Agreement | CRANFORD, N.J. and LOMBARD, Ill., June 20, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQX: ENZN) ("Enzon" or the "Company") and Viskase Companies, Inc. (OTC Pink Limited: VKSC) ("Viskase")... ► Artikel lesen | |
| ANI PHARMACEUTICALS | 82,50 | -1,20 % | 4 Analysts Have This To Say About ANI Pharmaceuticals | ||
| RIGEL PHARMACEUTICALS | 29,000 | -7,05 % | Rigel auf Investorenkonferenz: Strategisches Wachstum und Pipeline im Fokus | ||
| SAVARA | 3,320 | +1,22 % | Guggenheim raises Savara stock price target to $11 on manufacturing updates | ||
| MOLECULAR TEMPLATES | 0,107 | -0,56 % | NSE - Molecular Templates, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |
CORNERSTONE THERAPEUTICS INC gehört der Branche Pharma an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORNERSTONE THERAPEUTICS INC finden Sie auf Wallstreet Online.